Paul E Firuta - Net Worth and Insider Trading
Paul E Firuta Net Worth
The estimated net worth of Paul E Firuta is at least $2 Million dollars as of 2024-12-27. Paul E Firuta is the Chief Commercial Officer of uniQure NV and owns about 85,251 shares of uniQure NV (QURE) stock worth over $2 Million. Details can be seen in Paul E Firuta's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul E Firuta has not made any transactions after 2018-01-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul E Firuta
Paul E Firuta Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul E Firuta owns 2 companies in total, including Achillion Pharmaceuticals Inc (ACHN) , and uniQure NV (QURE) .
Click here to see the complete history of Paul E Firuta’s form 4 insider trades.
Insider Ownership Summary of Paul E Firuta
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACHN | Achillion Pharmaceuticals Inc | 2020-01-28 | EVP & Chief Commercial Officer |
| QURE | uniQure NV | 2018-01-26 | Chief Commercial Officer |
Paul E Firuta Latest Holdings Summary
Paul E Firuta currently owns a total of 1 stock. Paul E Firuta owns 85,251 shares of uniQure NV (QURE) as of January 3, 2018, with a value of $2 Million.
Latest Holdings of Paul E Firuta
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QURE | uniQure NV | 2018-01-03 | 85,251 | 17.73 | 1,511,500 |
Holding Weightings of Paul E Firuta
Paul E Firuta Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul E Firuta has made a total of 0 transactions in uniQure NV (QURE) over the past 5 years. The most-recent trade in uniQure NV is the sale of 5,864 shares on January 3, 2018, which brought Paul E Firuta around $118,042.
Insider Trading History of Paul E Firuta
- 1
Paul E Firuta Trading Performance
Paul E Firuta Ownership Network
Paul E Firuta Owned Company Details
What does Achillion Pharmaceuticals Inc do?
Who are the key executives at Achillion Pharmaceuticals Inc?
Paul E Firuta is the EVP & Chief Commercial Officer of Achillion Pharmaceuticals Inc. Other key executives at Achillion Pharmaceuticals Inc include EVP & Chief Medical Officer Steven Zelenkofske , General Counsel Martha E Manning , and director & Chief Executive Officer Joseph Truitt .
Achillion Pharmaceuticals Inc (ACHN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Achillion Pharmaceuticals Inc (ACHN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achillion Pharmaceuticals Inc (ACHN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Achillion Pharmaceuticals Inc (ACHN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Achillion Pharmaceuticals Inc Insider Transactions
Paul E Firuta Mailing Address
Above is the net worth, insider trading, and ownership report for Paul E Firuta. You might contact Paul E Firuta via mailing address: 550 Hills Drive, Third Floor, Bedminster Nj 07921.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
